X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1233) 1233
dibenzazepines - therapeutic use (1041) 1041
male (793) 793
female (744) 744
adult (699) 699
middle aged (594) 594
aged (337) 337
clinical trials as topic (312) 312
depression - drug therapy (298) 298
adolescent (230) 230
animals (227) 227
dibenzazepines - adverse effects (214) 214
dibenzazepines - pharmacology (214) 214
double-blind method (189) 189
clozapine - therapeutic use (174) 174
mianserin - therapeutic use (172) 172
schizophrenia - drug therapy (169) 169
index medicus (164) 164
pharmacology & pharmacy (163) 163
psychiatric status rating scales (155) 155
dibenzazepines - administration & dosage (145) 145
depressive disorder - drug therapy (128) 128
time factors (119) 119
drug evaluation (116) 116
clomipramine - therapeutic use (113) 113
anticonvulsants - therapeutic use (107) 107
clinical neurology (107) 107
clozapine - adverse effects (98) 98
rats (98) 98
dose-response relationship, drug (95) 95
antidepressive agents - therapeutic use (89) 89
placebos (88) 88
amitriptyline - therapeutic use (85) 85
mianserin - adverse effects (85) 85
trimipramine - therapeutic use (85) 85
psychiatry (83) 83
imipramine - therapeutic use (79) 79
epilepsy (78) 78
eslicarbazepine acetate (73) 73
electroencephalography (70) 70
carbamazepine - therapeutic use (69) 69
antiepileptic drugs (68) 68
tranquilizing agents - therapeutic use (68) 68
partial-onset seizures (65) 65
drug therapy, combination (64) 64
mice (64) 64
epilepsy - drug therapy (62) 62
child (61) 61
neurosciences (59) 59
oxcarbazepine (56) 56
carbamazepine (55) 55
administration, oral (54) 54
bipolar disorder - drug therapy (52) 52
anticonvulsants - adverse effects (51) 51
double-blind (51) 51
clozapine (50) 50
pharmacokinetics (49) 49
dibenzazepines - pharmacokinetics (48) 48
dibenzazepines - blood (47) 47
epilepsies, partial - drug therapy (47) 47
efficacy (46) 46
clozapine - pharmacology (44) 44
young adult (43) 43
adjustment disorders - drug therapy (42) 42
clomipramine - adverse effects (42) 42
psychotic disorders - drug therapy (41) 41
seizures (41) 41
treatment outcome (41) 41
analysis (40) 40
safety (39) 39
neurology (38) 38
obsessive-compulsive disorder - drug therapy (38) 38
chronic disease (37) 37
blood pressure - drug effects (35) 35
seizures - drug therapy (35) 35
anticonvulsants (34) 34
carbamazepine - analogs & derivatives (33) 33
dibenzazepines - chemistry (33) 33
trigeminal neuralgia - drug therapy (33) 33
depressive disorder - psychology (32) 32
eslicarbazepine (32) 32
adjunctive treatment (31) 31
adults (31) 31
anti-arrhythmia agents - therapeutic use (31) 31
dibenzazepines (31) 31
dibenzazepines - metabolism (31) 31
agranulocytosis - chemically induced (30) 30
antipsychotic agents - therapeutic use (30) 30
electrocardiography (30) 30
imidazoles - therapeutic use (30) 30
amitriptyline - adverse effects (29) 29
anticonvulsants - pharmacokinetics (29) 29
anxiety - drug therapy (29) 29
child, preschool (29) 29
drug interactions (29) 29
follow-up studies (29) 29
in vitro techniques (29) 29
rats, inbred strains (29) 29
antidepressive agents, tricyclic - therapeutic use (28) 28
kinetics (28) 28
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (963) 963
German (117) 117
French (104) 104
Russian (47) 47
Spanish (43) 43
Italian (35) 35
Polish (23) 23
Portuguese (15) 15
Czech (14) 14
Danish (12) 12
Norwegian (7) 7
Swedish (7) 7
Chinese (6) 6
Japanese (5) 5
Romanian (3) 3
Dutch (2) 2
Finnish (2) 2
Serbian (2) 2
Croatian (1) 1
Greek (1) 1
Hebrew (1) 1
Hungarian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Epilepsy and Behavior, ISSN 1525-5050, 2017, Volume 71, Issue Pt A, pp. 73 - 78
Abstract Psychiatric comorbidities are common in people with epilepsy. A retrospective study of characteristics associated with withdrawal due to psychiatric... 
Neurology | Antiepileptic drug | Side effects | Prospective audit | Epilepsy | Psychiatric | Seizures | DEPRESSION | POPULATION | REFRACTORY EPILEPSY | MENTAL-RETARDATION | PSYCHIATRY | CLINICAL NEUROLOGY | INTELLECTUAL DISABILITY | JUVENILE MYOCLONIC EPILEPSY | BEHAVIORAL SCIENCES | PEOPLE | ANXIETY DISORDERS | FOCAL EPILEPSY | LEVETIRACETAM | Pregabalin - adverse effects | Prospective Studies | Pregabalin - therapeutic use | Humans | Medical Audit - methods | Middle Aged | Piracetam - adverse effects | Seizures - drug therapy | Male | Young Adult | Anticonvulsants - adverse effects | Acetamides - therapeutic use | Piracetam - therapeutic use | Sodium Channel Blockers - adverse effects | Acetamides - adverse effects | Aged, 80 and over | Sodium Channel Blockers - therapeutic use | Adult | Female | Retrospective Studies | Mental Disorders - diagnosis | Epilepsy - psychology | Fructose - adverse effects | Mental Disorders - chemically induced | Dibenzazepines | Anticonvulsants - therapeutic use | Pyridones | Fructose - therapeutic use | Epilepsy - diagnosis | Mental Disorders - psychology | Fructose - analogs & derivatives | Piracetam - analogs & derivatives | Adolescent | Epilepsy - drug therapy | Aged | Drug-Related Side Effects and Adverse Reactions - diagnosis | Drug-Related Side Effects and Adverse Reactions - psychology | Seizures - psychology | Drugs | Complications and side effects | Anticonvulsants | Comorbidity | Learning disabilities | Seizures (Medicine) | Mental illness | Depression, Mental
Journal Article
Journal Article
Journal Article
Seizure: European Journal of Epilepsy, ISSN 1059-1311, 2013, Volume 22, Issue 7, pp. 528 - 536
Abstract Purpose Analysis of overall tolerability and neurological adverse effects (AEs) of eslicarbazepine acetate (ESL), lacosamide (LCM) and oxcarbazepine... 
Neurology | Oxcarbazepine | Eslicarbazepine | Adverse events | Antiepileptic drugs | Epilepsy | Lacosamide | ADULT PATIENTS | EFFICACY | SAFETY | CARBAMAZEPINE | TOXICITY | ADJUNCTIVE LACOSAMIDE | NEUROSCIENCES | CLINICAL NEUROLOGY | PARTIAL-ONSET SEIZURES | CONTROLLED-TRIALS | THERAPY | REFRACTORY PARTIAL EPILEPSY | Humans | Anticonvulsants - administration & dosage | Dose-Response Relationship, Drug | Nervous System Diseases - epidemiology | Anticonvulsants - adverse effects | Dibenzazepines - therapeutic use | Acetamides - therapeutic use | Carbamazepine - administration & dosage | Sodium Channel Blockers - adverse effects | Sodium Channel Blockers - administration & dosage | Acetamides - adverse effects | Sodium Channel Blockers - therapeutic use | Nervous System Diseases - physiopathology | Dizziness - epidemiology | Diplopia - chemically induced | Dibenzazepines - administration & dosage | Diplopia - epidemiology | Carbamazepine - analogs & derivatives | Double-Blind Method | Risk Assessment | Dizziness - chemically induced | Anticonvulsants - therapeutic use | Carbamazepine - therapeutic use | Treatment Outcome | Ataxia - epidemiology | Dibenzazepines - adverse effects | Randomized Controlled Trials as Topic | Carbamazepine - adverse effects | Nervous System Diseases - chemically induced | Ataxia - chemically induced | Acetamides - administration & dosage | Complications and side effects | Anticonvulsants | Analysis
Journal Article
Journal Article